NYXH (Nyxoah) Inventories, Raw Materials & Components: $1.42 Mil (As of Mar. 2026)


NYXH Nyxoah SA NYXH
60 GF Score
Price $1.68
GF Value $28.92
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Nyxoah Inventories, Raw Materials & Components?

Nyxoah NYXH 60 Inventories, Raw Materials & Components is $1.42 Mil as of Mar. 2026. GuruFocus rates NYXH with a GF Score™ of 60/100 and a GF Value™ of $28.92 (Possible Value Trap). The stock has 5 warning signs investors should review.

Nyxoah's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $1.42 Mil.

Nyxoah's quarterly raw materials declined from Sep. 2025 ($1.77 Mil) to Dec. 2025 ($1.54 Mil) and declined from Dec. 2025 ($1.54 Mil) to Mar. 2026 ($1.42 Mil).

Nyxoah's annual raw materials declined from Dec. 2023 ($1.45 Mil) to Dec. 2024 ($1.13 Mil) but then increased from Dec. 2024 ($1.13 Mil) to Dec. 2025 ($1.54 Mil).

Nyxoah Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Nyxoah's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nyxoah Inventories, Raw Materials & Components Chart

Nyxoah Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only 0.00 0.53 1.45 1.13 1.54

Nyxoah Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.49 1.77 1.54 1.42
NYXH
60GF Score
Nyxoah SA NYXH
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nyxoah Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $1.42 Mil mean?
Nyxoah (NYXH) has a Inventories, Raw Materials & Components of $1.42 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Nyxoah and its competitors.
Is Nyxoah's Inventories, Raw Materials & Components too high?
Nyxoah's current Inventories, Raw Materials & Components is $1.42 Mil. Overall, Nyxoah has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nyxoah's Inventories, Raw Materials & Components compare to ISRG and BDX?
Nyxoah's Inventories, Raw Materials & Components of $1.42 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Nyxoah and its competitors. Nyxoah's current Inventories, Raw Materials & Components is $1.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nyxoah stock overvalued right now?
Based on GuruFocus' analysis, Nyxoah (NYXH) is currently considered Possible Value Trap. The stock's GF Value™ is $28.92, compared to a current price of $1.68 — trading 94.2% below its estimated fair value. The current Inventories, Raw Materials & Components is $1.42 Mil. Nyxoah's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Nyxoah (NYXH), the current Inventories, Raw Materials & Components is $1.42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nyxoah (NYXH) Overvalued in 2026?

Based on GuruFocus' analysis, Nyxoah stock appears to be undervalued. The current stock price of $1.68 is trading 94.2% below its estimated GF Value™ of $28.92. GuruFocus considers Nyxoah to be Possible Value Trap.

Key valuation signals for NYXH:

  • Inventories, Raw Materials & Components: $1.42 Mil
  • GF Value™: $28.92 vs. price of $1.68 (94.2% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the NYXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nyxoah Business Description

Other Exchanges 5YI:GermanyNYXH:Belgium
Address Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
60GF Score

Get the complete analysis for NYXH

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.68
Price
$28.92
GF Value